DNA Ginkgo Bioworks Corp.: Price-to-Projected Revenue Ratio

Ginkgo Corp - graphic logo of issuer DNA

Unstable cash flow and high development costs create volatility reflected in the forward P/S of Ginkgo Bioworks Holdings (DNA), where the latest parameter stands at 5.10. However, the partnership with Google Cloud and contracts with pharmaceutical giants are driving growth. The phenomenal scaling potential of bio-code in food and medicine ensures high margins, despite the current phase of active liquidity investments.

DNA Ginkgo Bioworks Holdings, Inc.: Forward P/S Multiple in the range 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Ginkgo Bioworks Holdings (DNA)

- market price and analyst price targets:
Summary company analysis:DNA (Ginkgo Bioworks Holdings)
Manufactured products of Ginkgo Bioworks Corp.

The long-term reliability of Ginkgo Bioworks Holdings (DNA) is determined by the market's ability to capitalize future cash flows. This indicator measures the company's market value relative to its projected revenue, allowing for an assessment of the premium paid for future growth. By analyzing the projected price-to-sales ratio, an investor can see the balance between expectations and reality. High values here are justified by Ginkgo Bioworks Holdings (DNA)'s leadership in synthetic biology and the implementation of sustainable bio-alternatives to petrochemicals.

Competitor analysis

Price-to-Projected Revenue Ratio NVIDIA NVDA|Market Cap to Expected Sales Ratio CoreWeave Corp (CRWV)|NBIS - Price-to-Projected Revenue Ratio|SOUN - Forward P/S Multiple|ZETA: Forward P/S Multiple|PGY (Pagaya Technologies Ltd.) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple AI|RXRX: Forward Price to Sales|Price-to-Projected Revenue Ratio Rezolve AI Ltd (RZLV)|SUPX (superx.sg) - Forward Price to Sales|Forward P/S Multiple CRNC (Cerence Inc)|Forward Price to Sales PDYN|Veritone Inc. - Forward P/S Multiple|Market Cap to Future Revenue Ratio Mint Inc.|microalgor.com (MLGO) - Price-to-Projected Revenue Ratio|HPAI - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio LivePerson Corp|QUIK (QuickLogic Corporation) - Price to Expected Revenue Ratio|Price to Expected Revenue Ratio system1.com|Price to Expected Revenue Ratio DVLT|Price-to-Projected Revenue Ratio Ruanyun Edai RYET|Webus International Limited - Price-to-Projected Revenue Ratio|MCRP - Price-to-Projected Revenue Ratio|CYN (cyngn.com) - Market Cap to Projected Revenue|connexasports.com (YYAI) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio MicroCloud Hologram, Inc. (HOLO)|Forward Price-to-Revenue Multiple MSAI|Evaxion Biotech A/S (EVAX) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AIXI (Xiao-I Robot)|Forward Price-to-Revenue Multiple CXApp Corp CXAI|Price-to-Projected Revenue Ratio beninc.ai BNAI|Forward P/S Multiple Gaxos AI GXAI|EVGN - Price-to-Projected Revenue Ratio|IFBD: Price-to-Projected Revenue Ratio|Taoping Corp (TAOP) - Price-to-Projected Revenue Ratio|VSAI - Market Cap to Expected Sales Ratio|EXAI (Exscientia) - Forward P/S Multiple|FOXO (FOXO Technologies Inc.) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Vocodia Holdings Corp. (VHAI)|Forward P/S Multiple Zapata Computing Holdings Inc. (ZPTA)